Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FAVIPIRAVIR Cause Electrocardiogram qt prolonged? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Electrocardiogram qt prolonged have been filed in association with FAVIPIRAVIR. This represents 1.8% of all adverse event reports for FAVIPIRAVIR.

10
Reports of Electrocardiogram qt prolonged with FAVIPIRAVIR
1.8%
of all FAVIPIRAVIR reports
2
Deaths
3
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From FAVIPIRAVIR?

Of the 10 reports, 2 (20.0%) resulted in death, 3 (30.0%) required hospitalization.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FAVIPIRAVIR. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does FAVIPIRAVIR Cause?

Off label use (369) Drug ineffective (56) Drug ineffective for unapproved indication (40) Condition aggravated (29) Covid-19 (26) Disease progression (24) Product use in unapproved indication (18) Covid-19 pneumonia (15) Acute respiratory distress syndrome (14) Acute kidney injury (13)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which FAVIPIRAVIR Alternatives Have Lower Electrocardiogram qt prolonged Risk?

FAVIPIRAVIR vs FEBUXOSTAT FAVIPIRAVIR vs FEDRATINIB FAVIPIRAVIR vs FELBAMATE FAVIPIRAVIR vs FELIS CATUS HAIR FAVIPIRAVIR vs FELODIPINE

Related Pages

FAVIPIRAVIR Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged FAVIPIRAVIR Demographics